Category: Money tips Release Date: 2007-06-20
July 25 Zhongguancun Securities Xiaojing
Thumb through any newspaper over the weekend saw a lot of experts, the market exchange rate adjustment on the impact of the market outlook has made all kinds of speculation, some see more than others insist that watch, say, today. How afternoon tape will be how to get it? How we should operate to achieve risk minimization, revenue more? With this series of questions, I went back to the large room.
Xiao Erhei to see me so confused, so to me said: pros and cons of exchange rate adjustment will take some time to figure out, while technical analysis can help us to predict the short-term market's trend, so do not worry too much. The near future will be a rare short-term opportunities, the shot can act.
After listening to Xiao Erhei, then I regain confidence in the bold bought 1.86 yuan in Fujian Cement, while the Rhine-home 3.14 yuan profits, which come to one account I have added back a sum of income. Look at the broad market trend today, I was surprised to find that the forecast last Friday with Xiao Erhei exactly the same, I am more and more to admire Xiao Erhei.
Liu sister because of Yao City in the chase reached into the shares after the market closed, and she impatiently asked Xiao Erhei tomorrow will be how to get broader market.
Xiao Erhei Forecast: As the market lacks follow-up of funds to join, but they are also facing a certain degree of short-term profit-taking pressure, is expected tomorrow, finishing broader market will continue to maintain the pattern of oscillation.
Liu sister hear a long sigh of relief. She asked what Jessica Green of stocks.
Jessica Green Recommended Road: Huayuan Pharmaceutical [600,656] a subsidiary of the recent transfer of equity, containing events, worthy of attention. Benxi, Liaoning Huayuan company's stake in all the three drugs transferred to Beijing Pharmaceutical Group, access to 153 million in cash. In fact, Beijing Pharmaceutical Group is the company's largest shareholder, China Huayuan Industrial Co., Ltd., a subsidiary of life, so this is essentially a reorganization of behavior. Huayuan Pharmaceutical hand large amount of cash, reminiscent of the majority shareholder Huayuan Huayuan Pharmaceutical life will have to inject high quality assets, the follow-up deployment, I believe that the subject would Huayuan Pharmaceutical brings a wealth of imagination.
Huayuan Pharmaceutical subject matter is novel, Jessica Green indeed a unique vision. I also found a stock only 1 yuan, twice as strong growth in productivity in Qilian Mountain (600.72 thousand quotes, information, advice, Comments, more). With great strength of the domestic engineering giant Sinoma International strategic cooperation, the future will be developed into an annual output of 12 million tons of cement, annual sales revenues of more than 1.5 billion industry leader, compared to 2004 company 7 billion in annual income, performance to achieve double room for growth is extremely wide. Unit growth is expected to clear results, while the stock is currently only 1 yuan from 2.16 yuan per share has been net assets, the stock rose a vast space.
